Boston Pharmaceuticals

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Boston Pharmaceuticals is a translational drug development company. It was founded in 2016 by Chris Viehbacher, ex-CEO of Sanofi and Rob Armstrong, ex-R&D Executive from Eli Lilly. With $600M committed capital from Gurnet Point Capital, Boston Pharma’s business model is focused on partnering and developing therapeutics from late pre-clinical to clinical POC. In the past 4 years, we have built an experienced clinical development team and acquired a diverse portfolio of fifteen programs in oncology, autoimmune, cardiovascular, dermatology, anti-infective, gastrointestinal, and metabolic, including recent deals with GSK, Novartis, and other Pharma and biotech partners. In principle, we are agnostic with regards to indication or molecular modality. During this conference, we are seeking in licensing and out licensing partnering discussions.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
BOS161721
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
14
Speaker
photo
Chief Business Officer
Boston Pharmaceuticals